Omkar Pharmachem Ltd.BSE: OMKARPH

Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August, 2025

· Issued by Omkar Pharmachem Ltd. via BSE India

Filed with BSE ·

Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 13th August, 2025 has considered and approved the following business:1. Unaudited Financial Results of the Company for the quarter ended on 30th June, 2025

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Omkar Pharmachem Ltd. on 6ix

Earlier from Omkar Pharmachem

Later from Omkar Pharmachem

All Omkar Pharmachem news releases